Skip to content

GordonMD Global Investments LP

Follow

13F filer, CIK 2039349, Beverely Hills, CA

GordonMD Global Investments LP reported $166,469,374 across 14 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 85.68% of the portfolio.

Accepted , ingested 13F-HR 0000919574-26-007964

Period
2026-09-30
Reported value
$166M
Holdings
14
Top 10 weight
85.68%
New
3
Sold out
5

Part of the filer group GordonMD Global Investments LP

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TEVAnew+379,520$15M
PYXSadded+5,517,000$12.9M
TNGXnew+1,852,495$9.02M
ADRXnew+450,000$8.97M
KYTXadded+276,500$1.88M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TEVAexited-2,402,495-$16.4M
TSHAreduced-475,185-$11.9M
RAREexited-289,101-$9.65M
VIRreduced-550,000-$6.15M
SIONexited-136,000-$5.98M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000919574-26-007964, largest first. % of portfolio is the value over $166,469,374, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,121,870 shares; 2026Q1: 4,121,870 shares; 2026Q2: 10,024,909 shares; 2026Q3: 15,541,909 shares 15,541,909$36.2M21.75%+5,517,0002026-10-01, 13G/A: 20,441,948 shares, 16.4% of the class, 13G/A filed 2026-10-09 Timeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,391,818 shares; 2026Q1: 4,244,818 shares; 2026Q2: 4,244,818 shares; 2026Q3: 4,521,318 shares 4,521,318$30.7M18.47%+276,500Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 379,520 shares 379,520$15M9.03%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 170,307 shares; 2026Q1: 170,307 shares; 2026Q2: 279,720 shares; 2026Q3: 279,720 shares 279,720$9.07M5.45%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,852,495 shares 1,852,495$9.02M5.42%newTimeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 930,317 shares; 2026Q1: 1,518,552 shares; 2026Q2: 1,353,552 shares; 2026Q3: 803,552 shares 803,552$8.98M5.4%-550,000Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$8.97M5.39%newTimeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 1,430,000 shares; 2026Q2: 5,298,000 shares; 2026Q3: 5,298,000 shares 5,298,000$8.48M5.09%0Timeline
BLCOBAUSCH PLUS LOMB CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 613,472 shares; 2026Q1: 573,472 shares; 2026Q2: 573,472 shares; 2026Q3: 475,472 shares 475,472$8.08M4.86%-98,000Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,127,000 shares; 2026Q3: 3,127,000 shares 3,127,000$8.04M4.83%0Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 54,500 shares; 2026Q1: 43,300 shares; 2026Q2: 43,300 shares; 2026Q3: 51,080 shares 51,080$6.2M3.72%+7,780Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,330,901 shares; 2026Q1: 737,550 shares; 2026Q2: 723,185 shares; 2026Q3: 248,000 shares 248,000$6.19M3.72%-475,185Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 23,212 shares; 2026Q1: 20,212 shares; 2026Q2: 20,212 shares; 2026Q3: 14,512 shares 14,512$6.12M3.67%-5,700Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 132,500 shares; 2026Q2: 132,500 shares; 2026Q3: 110,500 shares 110,500$5.34M3.21%-22,000Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TEVATEVA PHARMACEUTICAL INDS LTD2,402,495$16.4Mshares
RAREULTRAGENYX PHARMACEUTICAL IN289,101$9.65Mshares
SIONSIONNA THERAPEUTICS INC136,000$5.98Mshares
CRNXCRINETICS PHARMACEUTICALS IN126,985$4.75Mshares
INSMINSMED INC28,587$3.05Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-26-007964 base2026-11-16